Cinzia Rodriguez is a QA Manager at CTMC, a joint venture between Resilience and MD Anderson Cancer Center, since May 2022, following a position as Biologics QA Supervisor at MD Anderson Cancer Center from April 2020 to May 2022. Previous roles include QS Specialist IV at Bellicum Pharmaceuticals, Inc. (April 2017 - April 2020), QA Specialist at Teva Pharmaceuticals (May 2009 - August 2016), QA Investigation Specialist/Product Coordinator at Patheon (November 2004 - March 2009), and Quality and Compliance Product Analyst at Wyeth Ayerst Laboratories (June 2002 - October 2004). Cinzia holds a Bachelor's degree in Biology from the University of Puerto Rico, Río Piedras, earned between 1996 and 2001. Expertise includes auditing and verifying manufacturing processes, implementing quality systems aligned with regulatory practices, and reviewing documentation for compliance.
This person is not in any offices
CTMC / A joint venture between Resilience + MD Anderson Cancer Center
Cell Therapy Manufacturing Center (CTMC) is a joint venture between Resilience and MD Anderson Cancer Center. CTMC was created to bring together the leading complex biologics manufacturing technology organization and the #1 clinical cancer center to enable innovation from academia and biotech to accelerate Cell Therapy’s impact for cancer patients.
Employees
51-200